Nadia Gennari

775 total citations
16 papers, 551 citations indexed

About

Nadia Gennari is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Nadia Gennari has authored 16 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Nadia Gennari's work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (5 papers) and Parasite Biology and Host Interactions (3 papers). Nadia Gennari is often cited by papers focused on Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (5 papers) and Parasite Biology and Host Interactions (3 papers). Nadia Gennari collaborates with scholars based in Italy, United States and Switzerland. Nadia Gennari's co-authors include M. Bellazzini, F. R. Ferraro, Frank Narjes, Michael Rowley, Sergio Altamura, Ian Stansfield, Alberto Bresciani, Raffaele De Francesco, Licia Tomei and Giovanni Migliaccio and has published in prestigious journals such as Analytical Biochemistry, Journal of Virology and Monthly Notices of the Royal Astronomical Society.

In The Last Decade

Nadia Gennari

16 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Gennari Italy 13 213 171 156 122 105 16 551
Ayşegül Özen United States 16 202 0.9× 373 2.2× 151 1.0× 309 2.5× 51 0.5× 22 744
Marija Prhavc United States 11 166 0.8× 388 2.3× 275 1.8× 358 2.9× 178 1.7× 30 798
Boris Feld United States 16 165 0.8× 197 1.2× 330 2.1× 177 1.5× 194 1.8× 26 724
Yeojin Park United States 13 180 0.8× 251 1.5× 207 1.3× 139 1.1× 37 0.4× 22 551
Jean Bernatchez United States 14 66 0.3× 201 1.2× 192 1.2× 287 2.4× 101 1.0× 46 713
Junxing Shi United States 16 213 1.0× 450 2.6× 244 1.6× 257 2.1× 202 1.9× 39 864
Sandrine Vendeville France 11 135 0.6× 144 0.8× 195 1.3× 184 1.5× 174 1.7× 15 519
Emanuela Nizi Italy 13 49 0.2× 159 0.9× 96 0.6× 238 2.0× 302 2.9× 19 609
Frederik Pauwels Belgium 14 335 1.6× 157 0.9× 387 2.5× 240 2.0× 41 0.4× 25 691
Shaoman Zhou United States 14 60 0.3× 146 0.9× 199 1.3× 102 0.8× 273 2.6× 27 564

Countries citing papers authored by Nadia Gennari

Since Specialization
Citations

This map shows the geographic impact of Nadia Gennari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Gennari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Gennari more than expected).

Fields of papers citing papers by Nadia Gennari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Gennari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Gennari. The network helps show where Nadia Gennari may publish in the future.

Co-authorship network of co-authors of Nadia Gennari

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Gennari. A scholar is included among the top collaborators of Nadia Gennari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Gennari. Nadia Gennari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ferrigno, Federica, Valentina Nardi, Rita Graziani, et al.. (2020). Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT. Bioorganic & Medicinal Chemistry Letters. 30(12). 127207–127207. 1 indexed citations
2.
Buonocore, Francesco, Simona Picchietti, Fernando Porcelli, et al.. (2019). Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens. Developmental & Comparative Immunology. 96. 9–17. 18 indexed citations
3.
Ferrigno, Federica, Savina Malancona, Giacomo Paonessa, et al.. (2018). Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3689–3692. 5 indexed citations
4.
Nizi, Emanuela, Alessio Sferrazza, Valentina Nardi, et al.. (2018). Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins. Bioorganic & Medicinal Chemistry Letters. 28(9). 1540–1544. 22 indexed citations
5.
Guidi, Alessandra, Fulvio Saccoccia, Nadia Gennari, et al.. (2018). Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production. Parasites & Vectors. 11(1). 668–668. 15 indexed citations
6.
Guidi, Alessandra, Emanuela Nizi, Nadia Gennari, et al.. (2017). Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. PLoS neglected tropical diseases. 11(10). e0005994–e0005994. 21 indexed citations
7.
Guidi, Alessandra, et al.. (2015). Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni. PLoS neglected tropical diseases. 9(1). e0003484–e0003484. 35 indexed citations
8.
Hernando, José Ignacio Martı́n, Jesus M. Ontoria, Savina Malancona, et al.. (2009). Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase. ChemMedChem. 4(10). 1695–1713. 22 indexed citations
9.
Ontoria, Jesus M., Edwin H. Rydberg, Stefania Di Marco, et al.. (2009). Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(16). 5217–5227. 40 indexed citations
10.
Gardelli, Cristina, Monica Donghi, Barbara Pacini, et al.. (2009). Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection. Journal of Medicinal Chemistry. 52(17). 5394–5407. 45 indexed citations
11.
Stansfield, Ian, Angela Mackay, Immacolata Conte, et al.. (2008). Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase. Bioorganic & Medicinal Chemistry Letters. 19(3). 627–632. 38 indexed citations
12.
Bellazzini, M., Nadia Gennari, & F. R. Ferraro. (2005). The red giant branch tip and bump of the Leo II dwarf spheroidal galaxy. Monthly Notices of the Royal Astronomical Society. 360(1). 185–193. 48 indexed citations
13.
Stansfield, Ian, Stefania Colarusso, Nadia Gennari, et al.. (2004). Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid. Bioorganic & Medicinal Chemistry Letters. 14(20). 5085–5088. 31 indexed citations
14.
Bellazzini, M., Nadia Gennari, F. R. Ferraro, & A. Sollima. (2004). The distance to the Leo I dwarf spheroidal galaxy from the red giant branch tip. Monthly Notices of the Royal Astronomical Society. 354(3). 708–712. 38 indexed citations
15.
Tomei, Licia, Sergio Altamura, Linda Bartholomew, et al.. (2003). Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase. Journal of Virology. 77(24). 13225–13231. 160 indexed citations
16.
Cerretani, Mauro, Laura Di Renzo, Sergio Serafini, et al.. (1999). A High-Throughput Radiometric Assay for Hepatitis C Virus NS3 Protease. Analytical Biochemistry. 266(2). 192–197. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026